FDA Approve GastroCHECK For Use In USA

Bedfont announce that the GastroCHECK is now available in the US following regulatory approval from the US Food and Drug Administration (FDA).

by Niki Carter | Monday 11 March 2013

The GastroCHECK is a portable breath monitor that measures Hydrogen (H2), Methane (CH4) and Oxyge(O2) for the purpose of aiding the diagnosis of gastrointestinal conditions such as:-

• Carbohydrate Breakdown Deficiency
• Lactose Intolerance
• Small instestinal Bacterial Overgrowth (SIBO)
• Determination of time passage through gut
• Irritable Bowel Syndrome (IBS)

The GastroCHECK allows health professionals to accurately detect a range of gastrointestinal disorders. An O2 reading is taken to motivate patients into providing an end-tidal sample. If the patient is unable to do this the GastroCH4ECK™ will automatically correct the reading saving the patient from embarrassment and having to carry out another test.

See: http://www.youtube.com/watch?v=eLBL-xdWvLQ&feature=youtu.be


Mrs Claudia Cuison
Bedfont Scientific Ltd
+44 (0) 1622 851122

Monday 11 March 2013 / file under Technology | Medical | Healthcare